How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3379-3383

  Rössle, Martin ^a   Siegerstetter, Volker ^a   Olschewski, Manfred ^b   Ochs, Andreas ^a   Berger, Elisabeth ^a   Haag, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; DECOMPRESSION; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VARICOSIS;

ADULT; BLOOD PRESSURE; FEMALE; HEMORRHAGE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PORTAL SYSTEM; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROBABILITY; RECURRENCE; SURVIVAL ANALYSIS; VARICOSE VEINS;

EID: 0035659639     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03902-8     Document Type: Article

References (26)

1. Variceal bleeding: Which shunt?
2. The role of TIPS for the treatment of portal hypertension: Effects and efficacy
3. Portacaval H-graft. Relationship of shunt diameter, portal flow patterns and hepatic encephalopathy
4. Predictability and maintenance of portal flow patterns after small-diameter H-grafts in man
5. Serial measurement of portal hemodynamics after partial portal decompression
6. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk factors
7. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors
8. Portal pressure, presence of gastroesophageal varices and bleeding
9. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
10. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial
11. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
12. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices
13. Portal hypertension and variceal bleeding: An AASLD single topic symposium
14. The implantation and maintenance of TIPS: Rules of the road and tricks of the trade
15. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
16. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
17. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding
18. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage
19. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
20. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease?
21. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
22. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding
23. Clinical versus haemodynamic response to drugs in portal hypertension
24. Failure of hemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol
25. Einfluβ von alkohol auf die hämodynamik der pfortader bei nutritiv-toxischer leberzirrhose